Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Joe Copia who wrote (1651)	5/4/1998 10:15:00 AM
From: Israel	Read Replies (2) \| Respond to of 25711

Joe.. believe someone mentioned NMED earlier.. though Id through in my DD.. Nutrition Medical, Inc. (NASDAQ: NMED) * Since going public in 96 at 3.50/share the stock has tumbled to 0.50 on Friday 04/01/98. Friday's volume was 190K shares. Last Q estimate was -0.07/sh and actual was + 0.01/sh * As per their last press release ( April 30, 1998) "The Company also noted that the divestiture of its retail business, announced in January, remains on schedule. The final steps of the transition are scheduled to be completed by May 1." The CEO added "The successful completion of this transaction will enable us to focus our energies solely on growing our clinical nutrition business. We are taking steps intended to sustain and bolster the growth that our clinical division experienced throughout the past year. * The company looks likes its turning around, focusing on its core business. Sales were up 56% during the last quarter. The company has a bout $ .20 cash on hand, which will increase with the sale of its retail operations. PR due out this week. * Company is currently selling for the value of Cash on hand. Address Nutrition Medical, Inc. and 9850 51st Ave. North, Suite 110 Name Plymouth, MN. 55442 Ph.#'s 612-551-9595 Fax. 612-551-9669 Own Public U.S company, (ticker symbol NMED) Formed 1993 Sales $2.5mil-$5mil annual sales CEO Willian L. Rush brush@Spacestar.com Industry Pharmaceuticals (PHA) Desc. The Company develops and sells nutrition products marketed as cost-effective, generic alternatives to equivalent national brand products. Initial development focused on branded generic formulas for the critical care nutrition market. These products are sold to hospitals and other health care facilities to feed critically ill patients who cannot consume adequate nutrients orally and consequently require specialized feeding via tubes into the intestinal tract. As of December 31, 1997, the Company had developed eight such products. Critical care nutrition products are generally purchased by a relatively large customer base, which typically places orders in relatively small quantities. Current 9/16 X 5/8 Quote 52wk L-3/8 H- 3 « range Avg. 20K shares. Vol. Shares Outstanding/ 5 million Float 3 million Chart: chart1.bigcharts.com:80/report?r=qchart&onbad=qbadsymbol&country=us&symb=NMED&qchart.x=87&qchart.y=20&sid=17756&sec=c&xyz=182768516&s=21890 Recent press releases: biz.yahoo.com April 30 biz.yahoo.com March 19 biz.yahoo.com March 02 biz.yahoo.com February 05 Sec filings: sec.yahoo.com Annual report March 31 sec.yahoo.com Quarterly report Nov. 12 sec.yahoo.com Quarterly report Aug. 14 sec.yahoo.com Quarterly report May 12 Yahoo Profile: biz.yahoo.com